Your browser doesn't support javascript.
loading
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Suwala, Abigail K; Stichel, Damian; Schrimpf, Daniel; Maas, Sybren L N; Sill, Martin; Dohmen, Hildegard; Banan, Rouzbeh; Reinhardt, Annekathrin; Sievers, Philipp; Hinz, Felix; Blattner-Johnson, Mirjam; Hartmann, Christian; Schweizer, Leonille; Boldt, Henning B; Kristensen, Bjarne Winther; Schittenhelm, Jens; Wood, Matthew D; Chotard, Guillaume; Bjergvig, Rolf; Das, Anirban; Tabori, Uri; Hasselblatt, Martin; Korshunov, Andrey; Abdullaev, Zied; Quezado, Martha; Aldape, Kenneth; Harter, Patrick N; Snuderl, Matija; Hench, Jürgen; Frank, Stephan; Acker, Till; Brandner, Sebastian; Winkler, Frank; Wesseling, Pieter; Pfister, Stefan M; Reuss, David E; Wick, Wolfgang; von Deimling, Andreas; Jones, David T W; Sahm, Felix.
Afiliación
  • Suwala AK; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Stichel D; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Schrimpf D; Department of Neurological Surgery, Helen Diller Research Center, University of California San Francisco, San Francisco, CA, USA.
  • Maas SLN; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sill M; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Dohmen H; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Banan R; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Reinhardt A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Sievers P; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hinz F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Blattner-Johnson M; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Hartmann C; Institute of Neuropathology, University of Giessen, Giessen, Germany.
  • Schweizer L; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Boldt HB; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Kristensen BW; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Schittenhelm J; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Wood MD; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Chotard G; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bjergvig R; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Das A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Tabori U; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hasselblatt M; Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Korshunov A; Department of Neuropathology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Abdullaev Z; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Quezado M; Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Aldape K; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Harter PN; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Snuderl M; Department of Clinical Medicine and Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Hench J; Institute of Pathology and Neuropathology, Department of Neuropathology, University Hospital Tübingen, Tübingen, Germany.
  • Frank S; Department of Pathology, Oregon Health and Science University, Portland, OR, USA.
  • Acker T; Department of Pathology, Hospital Center University of Bordeaux, Bordeaux, France.
  • Brandner S; Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Winkler F; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Wesseling P; Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
  • Pfister SM; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada.
  • Reuss DE; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Wick W; Institute of Neuropathology, University Hospital Münster, Munster, Germany.
  • von Deimling A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jones DTW; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Sahm F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Acta Neuropathol ; 142(1): 179-189, 2021 07.
Article en En | MEDLINE | ID: mdl-33876327
Glioblastoma IDH-wildtype presents with a wide histological spectrum. Some features are so distinctive that they are considered as separate histological variants or patterns for the purpose of classification. However, these usually lack defined (epi-)genetic alterations or profiles correlating with this histology. Here, we describe a molecular subtype with overlap to the unique histological pattern of glioblastoma with primitive neuronal component. Our cohort consists of 63 IDH-wildtype glioblastomas that harbor a characteristic DNA methylation profile. Median age at diagnosis was 59.5 years. Copy-number variations and genetic sequencing revealed frequent alterations in TP53, RB1 and PTEN, with fewer gains of chromosome 7 and homozygous CDKN2A/B deletions than usually described for IDH-wildtype glioblastoma. Gains of chromosome 1 were detected in more than half of the cases. A poorly differentiated phenotype with frequent absence of GFAP expression, high proliferation index and strong staining for p53 and TTF1 often caused misleading histological classification as carcinoma metastasis or primitive neuroectodermal tumor. Clinically, many patients presented with leptomeningeal dissemination and spinal metastasis. Outcome was poor with a median overall survival of only 12 months. Overall, we describe a new molecular subtype of IDH-wildtype glioblastoma with a distinct histological appearance and genetic signature.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Proteína p53 Supresora de Tumor / Tumores Neuroectodérmicos Primitivos / Glioblastoma / Metilación de ADN / Ubiquitina-Proteína Ligasas / Fosfohidrolasa PTEN / Proteínas de Unión a Retinoblastoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Proteína p53 Supresora de Tumor / Tumores Neuroectodérmicos Primitivos / Glioblastoma / Metilación de ADN / Ubiquitina-Proteína Ligasas / Fosfohidrolasa PTEN / Proteínas de Unión a Retinoblastoma Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Año: 2021 Tipo del documento: Article País de afiliación: Alemania